In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells

Endocrinology

Volumn 140, Issue 1, 1999, Pages 373-380

  Ferone, Diego ^a,b   Van Hagen, P Martin ^a   Van Koetsveld, Peter M ^a   Zuijderwijk, Joke ^a   Mooy, Diana M ^a   Lichtenauer Kaligis, Elgin G R ^a   Colao, Annamaria ^b   Bogers, Ad J J C ^a   Lombardi, Gaetano ^b   Lamberts, Steven W J ^d   Hofland, Leo J ^c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ARTICLE; AUTORADIOGRAPHY; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMUS;

EID: 0032952318     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.1.6398     Document Type: Article

References (38)

1. 1. Epelbaum J 1986 Somatostatin in central nervous system: physiology and pathological modification. Prog Neurobiol 27:63-100
2. 2. Reichlin S 1983 Somatostatin. N Engl J Med 309:1495-1501
3. 3. Reichlin S 1983 Somatostatin. N Engl J Med 309:1556-1563
4. 4. Lamberts SWJ, Krenning EP, Reubi JC 1991 The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12:450-482
5. 5. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffer P, Hoyer D, Lubbert M 1994 Molecular pharmacology of somatostatin-receptor subtypes. Ann N Y Acad Sci 733:138-146
6. 6 Reubi JC, Mauer R, von Weder K, Torhost J, Klijn GM, Lamberts SWJ 1987 Somatostatin receptors in human endocrine tumors. Cancer Res 47:551-558
7. 7. Reubi JC, Krenning E, Lamberts SWJ, Kvols L 1990 Somatostatin receptors in malignant tissues. J Steroid Biochem Mol Biol 37:1073-1077
8. 8. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S, Seino Y 1994 Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 93:1321-1325
9. 9 Lamberts SW, Bakker WH, Reubi JC, Krenning EP 1990 Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 323:1246-1249
10. 123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716-731
11. 11. Hofland LJ, Lamberts SWJ 1996 Somatostatin receptors and disease: role of receptor subtypes. Baillieres Clin Endocrinol Metab 10:163-176
12. 12 van Hagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, Anker-Lugtenburg PJ, Lowenberg B, Lamberts SWJ 1994 Somatostatin and the immune and haematopoietic system; a review. Eur J Clin Invest 24:91-99
13. 13. Stanisz AM, Befus D, Bienenstock J 1986 Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 136:152-156
14. 14. Fuller PJ, Verity K 1989 Somatostatin gene expression in the thymus gland. J Immunol 143:1015-1017
15. 15. Aguila MC, Dees WL, Haensly WE, McCann SM 1991 Evidence that somatostatin is localized and synthesized in lymphatic organs. Proc Natl Acad Sci USA 88:11485-11489
16. 16. Reubi JC, Waser B, Horisberger U, Krenning E, Lamberts SWJ, Gebbers J-O, Gersbach P, Laissue JA 1993 In vitro and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 82:2143-2151
17. 17. Cadigan DG, Hollett PD, Collingwood PW, Ur E 1996 Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue. Clin Nucl Med 21:487-488
18. 1]-Octreotide scintigraphy. J Nucl Med 39:634-639
19. 19. Palmieri G, Lastoria S, Colao A, Vergara E, Varrella P, Biondi E, Selleri C, Catalano L, Lombardi G, Bianco AR, Salvatore M 1997 Successful treatment of a patient with thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med 336:263-265
20. 20. Saalbach A, Anderegg U, Bruns M, Shnabel E, Herrmann K, Haustein UF 1996 Novel fibroblast-specific monoclonal antibodies: properties and specificities. J Invest Dermatol 106:1314-1319
21. 21. Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C 1990 Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 54:5969-5977
22. 22. Wulfsen I, Meyerhof W, Fehr S, Richter D 1993 Expression pattern of rat somatostatin receptor genes in pre-and postnatal brain and pituitary. J Neurochem 61:1549-1552
23. 23. Reubi JC 1985 New specific radioligand for one subpopulation of brain somatostatin receptors. Life Sci 36:1829-1836
24. 24. Millington G, Buckingham JC 1992 Thymic peptides and neuroendocrine-immune communication. J Endocrinol 133:163-168
25. 25. Mocchegiani E, Paolucci P, Balsamo A, Cacciari E, Fabris N 1990 Influence of growth hormone on thymic endocrine activity in humans. Horm Res 33:248-255
26. 26. Dardenne M, Savino W 1996 Interdependence of the endocrine and immune systems. Adv Neuroimmunol 6:297-307
27. 27. Timsit J, Savino W, Safieh B, Chanson P, Gagnerault MC, Bach JF, Dardenne M 1992 Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 75:183-188
28. 28. Sabharwal P, Varma S 1996 Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor-I as an autocrine and paracrine growth factor. J Clin Endocrinol Metab 81:2663-2669
29. 29. Buscail L, Delesque N, Esteve JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N, Susìni C 1994 Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogs: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 91:2315-2319
30. 30. Buscail L, Esteve JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carrol AM, Bell GI, Schally AV, Vaysse N, Susini C 1995 Inhibition of cell proliferation by somatostatin analog RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA 92:1580-1584
31. 31. Patel YC, Greenwood MT, Panetta R, Hukovic N, Grigorakis S, Robertson LA, Srikant CB 1995 The somatostatin receptor family. Life Sci 57:1249-1265
32. 32. Reubi JC, Laissue JA, Krenning E, Lamberts SWJ 1992 Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol 43:27-35
33. 33. Srikant CB 1995 Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary cell. Biochem Biophys Res Commun 209:400-406
34. 34. Sharma K, Patel YC, Srikant CB 1996 Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 10:1688-1696
35. 35. Tateyama H, Eimoto H, Tada T, Mizuno T, Inagaki H, Hata A, Sasaki M, Masaoka A 1995 p53 protein expression and p53 gene mutation in thymic epithelial tumours. Am J Clin Pathol 104:375-381
36. 36 Weirich G, Schneider P, Fellbaum C, Brauch H, Nathrath W, Scholz M, Praüer H, Höfler H 1997 p53 alterations in thymic epithelial tumours. Virchows Arch 431:17-23
37. 37. Andersen A, Pedersen H, Bendtzen K, Röpke C 1993 Effects of growth factors on cytokine production in serum-free cultures of human thymic epithelial cells. Scand J Immunol 38:233-238
38. 38. Klarlund JK 1985 Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell 41:707-717